Products > IHC > Antibodies for immunohistochemistry

Antibodies for immunohistochemistry

Reach out to the antigen

In addition to the well-known own brand Zytomed Systems, the current program includes tried and tested reagents from Diagnostic Biosystems, BioCare Medical, Zeta Corporation among others. We are constantly testing new antibodies and detection systems to meet the specific requirements of the laboratories and scientific users in the best possible way. Most of the primary antibodies are available both as concentrates and as ready-to-use products.

Sorry, no results could be found for your request.
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.
Host Mouse
Clone XM26
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:50 - 1:75
Isotype Mouse IgG1 kappa
Localization Cytoplasm
Cytokeratin 5 		XM26 MOB361
Host Mouse
Clone XM26
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:50 - 1:75
Isotype Mouse IgG1 kappa
Localization Cytoplasm
Cytokeratin 5 		XM26 MOB361-01
Host Mouse
Clone XM26
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:50 - 1:75
Isotype Mouse IgG1 kappa
Localization Cytoplasm
Cytokeratin 5 		XM26 MOB361-05
Host Mouse
Clone XM26
Format Ready-to-use
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution -
Isotype Mouse IgG1 kappa
Localization Cytoplasm
Cytokeratin 5 		XM26 PDM139
Host Rabbit
Clone EP42
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Lung squamous cell carcinoma
Dilution -
Isotype Rabbit IgG
Localization Cytoplasmic
Cytokeratin 5 		EP42 PME430AA
Host Monospecific Mouse
Clone ZM186
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Prostate.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant human Cytokeratin 5 (KRT5) protein fragment (around aa 318-491)
Localization Cytoplasm
Cytokeratin 5 		ZM186 Z2505ML
Host Monospecific Mouse
Clone ZM186
Format Ready-to-use
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Prostate.
Dilution -
Isotype IgG1 /κ
Immunogen Recombinant human Cytokeratin 5 (KRT5) protein fragment (around aa 318-491)
Localization Cytoplasm
Cytokeratin 5 		ZM186 Z2505MP
Host Monospecific Mouse
Clone ZM186
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Prostate.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant human Cytokeratin 5 (KRT5) protein fragment (around aa 318-491)
Localization Cytoplasm
Cytokeratin 5 		ZM186 Z2505MS
Host Monospecific Mouse
Clone ZM186
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Prostate.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant human Cytokeratin 5 (KRT5) protein fragment (around aa 318-491)
Localization Cytoplasm
Cytokeratin 5 		ZM186 Z2505MT
Host Mouse
Clone XM26
Format Concentrate
Method P
Pretreatment Reveal modified Citrate pH 6.0
Positive control Normal prostate
Dilution 1:25
Isotype Mouse IgG1 kappa
Localization Cytoplasmic
Cytokeratin 5 (CK5) 		XM26 CM234A
Host Mouse
Clone XM26
Format Concentrate
Method P
Pretreatment Reveal modified Citrate pH 6.0
Positive control Normal prostate
Dilution 1:25
Isotype Mouse IgG1 kappa
Localization Cytoplasmic
Cytokeratin 5 (CK5) 		XM26 CM234C
Host Mouse
Clone XM26
Format Ready-to-use
Method P
Pretreatment Reveal modified Citrate pH 6.0
Positive control Normal prostate
Dilution -
Isotype Mouse IgG1 kappa
Localization Cytoplasmic
Cytokeratin 5 (CK5) 		XM26 PM234AA
Host Mouse
Clone XM26+LL002
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse
Localization Cytoplasm
Cytokeratin 5 & 14 		XM26+LL002 MOB433
Host Mouse
Clone XM26+LL002
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse
Localization Cytoplasm
Cytokeratin 5 & 14 		XM26+LL002 MOB433-01
Host Mouse
Clone XM26+LL002
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse
Localization Cytoplasm
Cytokeratin 5 & 14 		XM26+LL002 MOB433-05
Host Mouse
Clone XM26+LL002
Format Ready-to-use
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution -
Isotype Mouse
Localization Cytoplasm
Cytokeratin 5 & 14 		XM26+LL002 PDM140
Host Mouse
Clone XM26+BC4A4
Format Ready-to-use
Method P
Pretreatment Reveal modified Citrate pH 6.0
Positive control Normal breast, ductal cell carcinoma
Dilution -
Isotype Mouse IgG1+IgG2a
Localization Cytoplasmic and nuclear
Cytokeratin 5 + p63 		XM26+BC4A4 PM235AA
Host Mouse
Clone XM26+BC4A4
Format Ready-to-use
Method P
Pretreatment Reveal modified Citrate pH 6.0
Positive control Normal breast, ductal cell carcinoma
Dilution -
Isotype Mouse IgG1+IgG2a
Localization Cytoplasmic and nuclear
Cytokeratin 5 + p63 		XM26+BC4A4 PM235H
Host Mouse
Clone D5-16B4
Format Concentrate
Reactivity -
Method P
Positive control Mesothelioma, prostate.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Isolated Cytokeratin 5
Localization Cytoplasm
Cytokeratin 5/6 		D5-16B4 Z2133ML
Host Mouse
Clone D5-16B4
Format Ready-to-use
Reactivity -
Method P
Positive control Mesothelioma, prostate.
Dilution -
Isotype IgG1 /κ
Immunogen Isolated Cytokeratin 5
Localization Cytoplasm
Cytokeratin 5/6 		D5-16B4 Z2133MP
Host Mouse
Clone D5-16B4
Format Concentrate
Reactivity -
Method P
Positive control Mesothelioma, prostate.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Isolated Cytokeratin 5
Localization Cytoplasm
Cytokeratin 5/6 		D5-16B4 Z2133MS
Host Mouse
Clone D5-16B4
Format Concentrate
Reactivity -
Method P
Positive control Mesothelioma, prostate.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Isolated Cytokeratin 5
Localization Cytoplasm
Cytokeratin 5/6 		D5-16B4 Z2133MT
Host Mouse
Clone CK5/6.007
Format Concentrate
Method P
Pretreatment EDTA o Citrate
Positive control Prostate or skin
Dilution 1:100
Isotype Mouse IgG1
Immunogen CK5/6
Localization Cytoplasmic
Cytokeratin 5/6 (CK 5/6) 		CK5/6.007 CM105C
Host Mouse+Rabbit
Clone XM26+LL002+4A4+BC1+EP30
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Breast cancer
Dilution -
Isotype IgG1/kappa, IgG3, IgG2a/kappa, Rabbit IgG
Localization Cytoplasmic and nuclear
Cytokeratin 5/14 + p63 + Cytokeratin 7/18 (ADH-5) 		XM26+LL002+4A4+BC1+EP30 PM360DSAA
Host Mouse+Rabbit
Clone XM26+LL002+4A4+BC1+EP30
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Breast cancer
Dilution -
Isotype IgG1/kappa, IgG3, IgG2a/kappa, Rabbit IgG,
Localization Cytoplasmic and nuclear
Cytokeratin 5/14 + p63 + Cytokeratin 7/18 (ADH-5) 		XM26+LL002+4A4+BC1+EP30 PM360DSH
Host Mouse+Rabbit
Clone XM26+LL002+4A4+polyclonal
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Prostate intraepithelial neoplasia PIN
Dilution -
Isotype MouseIgG1/kappa+IgG3+IgG2a/kappa+not determined
Localization Cytoplasmic and nuclear
Cytokeratin 5/14 + p63 + P504S 		XM26+LL002+4A4+polyclonal PPM225DSAA
Host Mouse+Rabbit
Clone XM26+LL002+4A4+polyclonal
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Prostate intraepithelial neoplasia PIN
Dilution -
Isotype MouseIgG1/kappa+IgG3+IgG2a/kappa+not determined
Localization Cytoplasmic and nuclear
Cytokeratin 5/14 + p63 + P504S 		XM26+LL002+4A4+polyclonal PPM225DSH
Host Rabbit
Clone BC1
Format Concentrate
Method P
Pretreatment Citrate
Positive control Ovarian cancer, breast cancer
Dilution 1:100 - 1:200
Isotype Rabbit IgG
Localization Cytoplasmic
Cytokeratin 7 		BC1 CRM339A
Host Rabbit
Clone BC1
Format Concentrate
Method P
Pretreatment Citrate
Positive control Ovarian cancer, breast cancer
Dilution 1:100 - 1:200
Isotype Rabbit IgG
Localization Cytoplasmic
Cytokeratin 7 		BC1 CRM339C
Host Rabbit
Clone BC1
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Ovarian cancer, breast cancer
Dilution -
Isotype Rabbit IgG
Localization Cytoplasmic
Cytokeratin 7 		BC1 PRM339AA
Host Mouse
Clone OV-TL-12:30
Format Concentrate
Reactivity -
Method P
Positive control Ovarian carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen OTN II ovarian carcinoma cell line
Localization Cytoplasm
Cytokeratin 7 		OV-TL-12:30 Z2067ML
Host Mouse
Clone OV-TL-12:30
Format Ready-to-use
Reactivity -
Method P
Positive control Ovarian carcinoma.
Dilution -
Isotype IgG1 /κ
Immunogen OTN II ovarian carcinoma cell line
Localization Cytoplasm
Cytokeratin 7 		OV-TL-12:30 Z2067MP
Host Mouse
Clone OV-TL-12:30
Format Concentrate
Reactivity -
Method P
Positive control Ovarian carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen OTN II ovarian carcinoma cell line
Localization Cytoplasm
Cytokeratin 7 		OV-TL-12:30 Z2067MS
Host Mouse
Clone OV-TL-12:30
Format Concentrate
Reactivity -
Method P
Positive control Ovarian carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen OTN II ovarian carcinoma cell line
Localization Cytoplasm
Cytokeratin 7 		OV-TL-12:30 Z2067MT
Host Mouse
Clone LP1K
Format Concentrate
Method P
Pretreatment Fast Enzyme
Positive control Tonsil
Dilution 1:50 - 1:100
Isotype IgG1
Immunogen Sonicated cytoskeleton fractions from SV40 transformed neonatal keratinocytes
Localization Cytoplasm
Cytokeratin 7 (LP1K) 		LP1K MOB563
Host Mouse
Clone LP1K
Format Concentrate
Method P
Pretreatment Fast Enzyme
Positive control Tonsil
Dilution 1:50 - 1:100
Isotype IgG1
Immunogen Sonicated cytoskeleton fractions from SV40 transformed neonatal keratinocytes
Localization Cytoplasm
Cytokeratin 7 (LP1K) 		LP1K MOB563-01
Host Mouse
Clone LP1K
Format Concentrate
Method P
Pretreatment Fast Enzyme
Positive control Tonsil
Dilution 1:50 - 1:100
Isotype IgG1
Immunogen Sonicated cytoskeleton fractions from SV40 transformed neonatal keratinocytes
Localization Cytoplasm
Cytokeratin 7 (LP1K) 		LP1K MOB563-05
Host Mouse
Clone LP1K
Format Ready-to-use
Method P
Pretreatment Fast Enzyme
Positive control Tonsil
Dilution -
Isotype IgG1
Immunogen Sonicated cytoskeleton fractions from SV40 transformed neonatal keratinocytes
Localization Cytoplasm
Cytokeratin 7 (LP1K) 		LP1K PDM563
Host Mouse
Clone LP1K
Format Ready-to-use
Method P
Pretreatment Fast Enzyme
Positive control Tonsil
Dilution -
Isotype IgG1
Immunogen Sonicated cytoskeleton fractions from SV40 transformed neonatal keratinocytes
Localization Cytoplasm
Cytokeratin 7 (LP1K) 		LP1K PDM563-25
Host Rabbit
Clone SP102
Format Concentrate
Reactivity BV, MS, PG, RT
Method P
Pretreatment Citrate
Positive control Breast ductal carcinoma
Dilution 1:100
Isotype Rabbit IgG
Immunogen Synthetic peptide corresponding to C-terminus of human keratin 8
Localization Cytoplasm, Cell Membrane
Cytokeratin 8 		SP102 503-4022
Host Rabbit
Clone SP102
Format Concentrate
Reactivity BV, MS, PG, RT
Method P
Pretreatment Citrate
Positive control Breast ductal carcinoma
Dilution 1:100
Isotype Rabbit IgG
Immunogen Synthetic peptide corresponding to C-terminus of human keratin 8
Localization Cytoplasm, Cell Membrane
Cytokeratin 8 		SP102 503-4024
Host Mouse
Clone 35ßH11
Format Concentrate
Method F, P
Pretreatment Citrate, Pepsin or Fast Enzyme
Positive control Skin
Dilution 1:10 - 1:25
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 8 		35ßH11 MOB054
Host Mouse
Clone 35ßH11
Format Concentrate
Method F, P
Pretreatment Citrate, Pepsin or Fast Enzyme
Positive control Skin
Dilution 1:10 - 1:25
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 8 		35ßH11 MOB054-01
Host Mouse
Clone 35ßH11
Format Concentrate
Method F, P
Pretreatment Citrate, Pepsin or Fast Enzyme
Positive control Skin
Dilution 1:10 - 1:25
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 8 		35ßH11 MOB054-05
Host Mouse
Clone 35ßH11
Format Ready-to-use
Method F, P
Pretreatment Citrate, Pepsin or Fast Enzyme
Positive control Skin
Dilution -
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 8 		35ßH11 PDM117
Host Mouse
Clone ZM123
Format Concentrate
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant full-length human KRT8 protein
Localization Cytoplasm
Cytokeratin 8 		ZM123 Z2433ML
Host Mouse
Clone ZM123
Format Ready-to-use
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution -
Isotype IgG1 /κ
Immunogen Recombinant full-length human KRT8 protein
Localization Cytoplasm
Cytokeratin 8 		ZM123 Z2433MP
Host Mouse
Clone ZM123
Format Concentrate
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant full-length human KRT8 protein
Localization Cytoplasm
Cytokeratin 8 		ZM123 Z2433MS
Host Mouse
Clone ZM123
Format Concentrate
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant full-length human KRT8 protein
Localization Cytoplasm
Cytokeratin 8 		ZM123 Z2433MT
Host Rabbit
Clone EP7 + EP30
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Colon cancer
Dilution -
Isotype IgG
Localization Cytoplasm
Cytokeratin 8 & 18 		EP7 + EP30 API3161AA
< Page 20 of 65 >
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.
Load more

Key to the method:

EL = ELISA; F = Frozen section IHC; FL = Flow Cytometry; IF = Immunfluoreszenz; IP = Immunoprecipitation; P = Paraffin section IHC; WB = Western Blot; u. a. = and others

Products

Topics

Learning videos

Downloads

Company

Distributors

Privacy Imprint
DE EN

Product availability

Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.

Got it